Google URL Tricks Made Easy
5 weeks ago
Friday, October 9, 2009
Tuesday, October 6, 2009
Monday, October 5, 2009
Adobe Flash and the iPhone
Adobe Shows Off Flash Apps For iPhone. Yes, You Read That Right.: "
More information is available here and soon, also here.
These are the example applications that you can test now if you have an iPhone or iPod Touch (any model):
Direct links:
Basically, Flash Pro CS5 allows developers to use Flash technologies to develop content for iPhone and iPod Touch devices that were previously closed to them. The Flash developer tool converts Flash apps into ones that can work on the iPhone, since the iPhone still does not support Flash. So this is a workaround. But developers can write new code or reuse existing web content to build applications for the devices, and because the source code and assets are reusable across the Flash Platform runtimes (Adobe AIR and Flash Player) it is aimed to also give developers a way to more easily target other mobile and desktop environments.
Note that this does not mean you’ll be able to watch Flash-based web content on your iPhone just yet:
The new support for iPhone applications in the Flash Platform tooling will not allow iPhone users to browse web content built with Flash technology on iPhone, but it may allow developers to repackage existing web content as applications for iPhone if they choose to do so. Flash Player uses a just-in-time compiler and virtual machine within a browser plug-in to play back content on websites. Those technologies are not allowed on the iPhone at this time, so a Flash Player for iPhone is not being made available today. Flash Professional CS5 will enable developers to build applications for iPhone that are installed as native applications. Users will be able to access the apps after downloading them from Apple’s App Store and installing them on iPhone or iPod Touch.More information is available here and soon, also here.
These are the example applications that you can test now if you have an iPhone or iPod Touch (any model):
Direct links:
Chroma Circuit
Trading Stuff
Ficklebox
Just Letters
South Park
That Roach Game
Red Hood
Thursday, October 1, 2009
Is Bing a Better Place to Browse iPhone Apps?
Is Bing a Better Place to Browse iPhone Apps?: "
Visual Search is the perfect solution if you’re trying to find info on an NFL quarterback but can’t remember his name, or if you need a quick refresher of Billboard number ones for the past few decades. And since it’s built using Microsoft Silverlight technology, the search process flows seamlessly and provides a visually entertaining experiment.
After careful inspection, you’ll also notice that one of Bing’s image galleries exists to make it easier for you to search and find iPhone apps. Yes, Microsoft has developed an arguably better interface for finding and exploring applications for their competitor’s device.
Listed towards the bottom of the main page, “Top iPhone apps,” includes 500 iPhone apps that you can sort by popularity, price, release date, or name. You can also filter to view applications in these categories: top 10 free, top 10 paid, newest, most expensive, games, entertainment, and social networking.
There’s even a way to narrow apps by their store category, price range, or publisher, with options for adding and removing multiple criteria to your visual search. You can also use the scrolling bar on the right to visually breeze though thumbnail app images. Mousing over any of the images in the gallery will highlight an individual app’s metadeta, displaying its category, price, rank, and release date immediately under the search box.
We never thought we’d say this, but Microsoft has built one truly impressive way to browse iPhone apps. Though not perfect — iTunes links would be desirable — Apple could certainly stand to learn a few things from the multi-criteria search functions.
Wednesday, September 30, 2009
Monday, September 28, 2009
Friday, September 25, 2009
Thursday, September 24, 2009
Monday, September 21, 2009
Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why.
Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why.
Extract:
From 2001 to 2006, the percentage of new products cut from development after Phase II clinical trials, when drugs are first tested against placebo, rose by 20 percent. The failure rate in more extensive Phase III trials increased by 11 percent, mainly due to surprisingly poor showings against placebo. Despite historic levels of industry investment in R&D, the US Food and Drug Administration approved only 19 first-of-their-kind remedies in 2007—the fewest since 1983—and just 24 in 2008. Half of all drugs that fail in late-stage trials drop out of the pipeline due to their inability to beat sugar pills.
Extract:
From 2001 to 2006, the percentage of new products cut from development after Phase II clinical trials, when drugs are first tested against placebo, rose by 20 percent. The failure rate in more extensive Phase III trials increased by 11 percent, mainly due to surprisingly poor showings against placebo. Despite historic levels of industry investment in R&D, the US Food and Drug Administration approved only 19 first-of-their-kind remedies in 2007—the fewest since 1983—and just 24 in 2008. Half of all drugs that fail in late-stage trials drop out of the pipeline due to their inability to beat sugar pills.
The upshot is fewer new medicines available to ailing patients and more financial woes for the beleaguered pharmaceutical industry. Last November, a new type of gene therapy for Parkinson's disease, championed by the Michael J. Fox Foundation, was abruptly withdrawn from Phase II trials after unexpectedly tanking against placebo. A stem-cell startup called Osiris Therapeutics got a drubbing on Wall Street in March, when it suspended trials of its pill for Crohn's disease, an intestinal ailment, citing an "unusually high" response to placebo. Two days later, Eli Lilly broke off testing of a much-touted new drug for schizophrenia when volunteers showed double the expected level of placebo response.
It's not only trials of new drugs that are crossing the futility boundary. Some products that have been on the market for decades, like Prozac, are faltering in more recent follow-up tests. In many cases, these are the compounds that, in the late '90s, made Big Pharma more profitable than Big Oil. But if these same drugs were vetted now, the FDA might not approve some of them. Two comprehensive analyses of antidepressant trials have uncovered a dramatic increase in placebo response since the 1980s. One estimated that the so-called effect size (a measure of statistical significance) in placebo groups had nearly doubled over that time.
It's not that the old meds are getting weaker, drug developers say. It's as if the placebo effect is somehow getting stronger.
Brainshark Takes on Slideshare
Brainshark Launches Free Service: Takes on Slideshare: "
Sunday, September 20, 2009
Mobile Devices for Nursing: a Comparative Human Factors Evaluation
Tara McCurdie at Med 2.0
Nothing about use with patients for education
Nothing about use with patients for education
Paul Grundy, MD, Patient-Centered Medical Home champion
Saturday, September 19, 2009
My sort of unconference
The BIL:PIL 2009 Healthcare Innovation Conference will bring together over 200 entrepreneurs, health professionals, technologists, and laypeople to describe the future of healthcare
BIL = Benevolence. Inspiration. Levity
BIL = Benevolence. Inspiration. Levity
Thursday, September 17, 2009
Subscribe to:
Posts (Atom)
Posts
